Ascentage Pharma Group International (HKG: 6855)
Hong Kong
· Delayed Price · Currency is HKD
42.10
+1.40 (3.44%)
Oct 10, 2024, 4:08 PM HKT
Ascentage Pharma Group International Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 13,034 | 7,772 | 6,636 | 7,264 | 8,500 | 6,109 | |
Market Cap Growth | 31.66% | 17.11% | -8.65% | -14.53% | 39.14% | - | |
Enterprise Value | 13,690 | 7,885 | 6,475 | 6,225 | 8,105 | 8,099 | |
Last Close Price | 42.10 | 27.30 | 25.70 | 28.20 | 38.50 | 30.00 | |
PE Ratio | - | -7.56 | -6.79 | -7.48 | -10.33 | -2.11 | |
PS Ratio | 12.62 | 31.78 | 27.99 | 212.05 | 574.86 | 376.27 | |
PB Ratio | 15.82 | 99.87 | 14.36 | 4.79 | 8.45 | 6.13 | |
P/FCF Ratio | -9.93 | -9.14 | -6.85 | -5.69 | -8.32 | -10.15 | |
P/OCF Ratio | -10.33 | -9.72 | -8.98 | -9.79 | -11.73 | -11.86 | |
EV/Sales Ratio | 14.11 | 32.24 | 27.31 | 181.70 | 548.18 | 498.86 | |
EV/EBITDA Ratio | -30.71 | -8.81 | -6.85 | -5.54 | -10.22 | -12.14 | |
EV/EBIT Ratio | -23.48 | -8.02 | -6.48 | -5.43 | -9.97 | -11.81 | |
EV/FCF Ratio | -17.20 | -9.27 | -6.68 | -4.88 | -7.94 | -13.46 | |
Debt / Equity Ratio | 2.19 | 25.42 | 4.39 | 0.88 | 0.63 | 0.11 | |
Debt / FCF Ratio | -2.30 | -2.33 | -2.09 | -1.04 | -0.62 | -0.19 | |
Asset Turnover | 0.30 | 0.08 | 0.07 | 0.01 | 0.01 | 0.01 | |
Inventory Turnover | 3.49 | 2.38 | 3.29 | - | - | - | |
Quick Ratio | 1.73 | 1.35 | 1.78 | 5.05 | 3.77 | 4.39 | |
Current Ratio | 1.84 | 1.44 | 1.86 | 5.22 | 3.91 | 4.50 | |
Return on Equity (ROE) | -52.38% | -386.28% | -107.45% | -75.18% | -78.02% | - | |
Return on Assets (ROA) | -7.14% | -20.92% | -19.14% | -24.97% | -29.14% | -31.48% | |
Return on Capital (ROIC) | -9.05% | -27.41% | -24.43% | -31.57% | -36.13% | -36.53% | |
Earnings Yield | -4.90% | -13.12% | -15.04% | -13.22% | -9.47% | -27.12% | |
FCF Yield | -10.07% | -10.95% | -14.60% | -17.57% | -12.01% | -9.85% | |
Buyback Yield / Dilution | -8.10% | -7.07% | -3.56% | -17.93% | -84.97% | -40.52% | |
Total Shareholder Return | -8.10% | -7.07% | -3.56% | -17.93% | -84.97% | -40.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.